29 November 2018 - Executives at pharmacy benefits managers have welcomed the new proposed rules.
When the Trump administration outlined its drug pricing blue print last summer, pharmacy benefit managers seemed to be squarely in the cross hairs for reform.
This week, as the administration unveiled new proposals for shaping drug coverage for Medicare Part D pharmacy plans, it became clear that benefits managers are now not so much targets but rather key players, who will carry the ball on drug price negotiations for the government.